☰

Eric G. Meissner, Ph.D. - Publications

Affiliations: 
2005 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Microbiology Biology, Pathology
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Adekunle RO, Kirk S, Williams J, Hanson R, Moreland-Johnson A, Fonner V, Gebregziabher M, Meissner EG. Receipt of Injectable HIV Treatment in Clinic Versus at Home: Perspectives of Persons Living with HIV Infection. Aids Patient Care and Stds. 37: 428-431. PMID 37713288 DOI: 10.1089/apc.2023.0154  0.467
2023 Fonner V, Agostini T, Desai R, Hartzell P, Martin L, Meissner EG. Implementation of free-draft text messaging to enhance care retention and satisfaction for persons living with HIV infection. Aids Care. 1-11. PMID 37139535 DOI: 10.1080/09540121.2023.2208320  0.359
2023 Lopez CM, Moreland A, Goodrum NM, Davies F, Meissner EG, Danielson CK. Association of mental health symptoms on HIV care outcomes and retention in treatment. General Hospital Psychiatry. 82: 41-46. PMID 36934530 DOI: 10.1016/j.genhosppsych.2023.03.003  0.357
2022 Muiruri C, Corneli A, Cooper L, Dombeck C, Gray S, Longenecker CT, Meissner EG, Okeke NL, Pettit AC, Swezey T, Vicini J, Bloomfield GS. Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study. Bmc Health Services Research. 22: 623. PMID 35534889 DOI: 10.1186/s12913-022-08015-0  0.442
2021 Novotny LA, Evans JG, Su L, Guo H, Meissner EG. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies. Viruses. 13. PMID 34207487 DOI: 10.3390/v13061090  0.506
2021 Novotny LA, Evans JG, Su L, Guo H, Meissner EG. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies. Viruses. 13. PMID 34207487 DOI: 10.3390/v13061090  0.506
2020 Meissner EG, Chung D, Tsao B, Haas D, Utay N. IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in Persons Living with HIV. Aids Research and Human Retroviruses. PMID 33066718 DOI: 10.1089/AID.2020.0104  0.425
2020 Okeke NL, Schafer KR, Meissner EG, Ostermann J, Shah AD, Ostasiewski B, Phelps E, Kieler CA, Oladele E, Garg K, Naggie S, Bloomfield GS, Bosworth HB. Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter? Open Forum Infectious Diseases. 7: ofaa361. PMID 32995348 DOI: 10.1093/ofid/ofaa361  0.344
2020 Muiruri C, Longenecker CT, Meissner EG, Okeke NL, Pettit AC, Thomas K, Velazquez E, Bloomfield GS. Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature. Progress in Cardiovascular Diseases. PMID 32057785 DOI: 10.1016/j.pcad.2020.02.006  0.376
2019 Gedney R, Butler Willis K, O'Brien A, Luciano M, Richardson KJ, Meissner EG. Identification of Priority Areas for Increased Testing Using Geospatial Mapping of Incident HIV Cases Near Charleston, South Carolina. Infectious Diseases. 12: 1178633719870759. PMID 31467478 DOI: 10.1177/1178633719870759  0.346
2018 Tolson C, Richey LE, Zhao Y, Korte JE, Brady K, Haynes L, Meissner EG. Association of Substance Use With Hospitalization and Virologic Suppression in a Southern Academic HIV Clinic. The American Journal of the Medical Sciences. 355: 553-558. PMID 29891038 DOI: 10.1016/j.amjms.2018.03.002  0.46
2017 Luo Z, Li Z, Martin L, Wan Z, Meissner EG, Espinosa E, Wu H, Yu X, Fu P, Westerink MAJ, Kilby JM, Wu J, Huang L, Heath SL, Li Z, et al. Pathological role of anti-CD4 antibodies in HIV-infected immunologic non-responders under viral suppressive antiretroviral therapy. The Journal of Infectious Diseases. PMID 28498953 DOI: 10.1093/Infdis/Jix223  0.419
2017 Meissner EG. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era. Current Opinion in Gastroenterology. PMID 28234770 DOI: 10.1097/MOG.0000000000000347  0.372
2016 Eckard AR, Meissner EG, Singh I, McComsey GA. Cardiovascular Disease, Statins, and HIV. The Journal of Infectious Diseases. 214: S83-92. PMID 27625435 DOI: 10.1093/Infdis/Jiw288  0.491
2015 Luo Z, Ma L, Zhang L, Martin L, Wan Z, Warth S, Kilby A, Gao Y, Bhargava P, Li Z, Wu H, Meissner EG, Li Z, Kilby JM, Liao G, et al. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine. PMID 26721328 DOI: 10.1016/J.Vaccine.2015.12.038  0.378
2015 Osinusi A, Townsend K, Kohli A, Nelson A, Seamon C, Meissner EG, Bon D, Silk R, Gross C, Price A, Sajadi M, Sidharthan S, Sims Z, Herrmann E, Hogan J, et al. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. Jama. 313: 1232-9. PMID 25706232 DOI: 10.1001/Jama.2015.1373  0.391
2012 Meissner EG, Suffredini AF, Kottilil S. Opportunities in proteomics to understand hepatitis C and HIV coinfection. Future Virology. 7: 759-765. PMID 23105947 DOI: 10.2217/fvl.12.67  0.39
2012 Meissner EG, Suffredini AF, Kottilil S. Opportunities in proteomics to understand hepatitis C and HIV coinfection Future Virology. 7: 759-765. DOI: 10.2217/fvl.12.67  0.419
2010 Zhang LG, Meissner E, Chen JZ, Su LS. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis Science China Life Sciences. 53: 195-203. PMID 20596827 DOI: 10.1007/S11427-010-0059-7  0.599
2009 Sivaraman V, Zhang L, Meissner EG, Jeffrey JL, Su L. The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env. Journal of Virology. 83: 11715-25. PMID 19726524 DOI: 10.1128/Jvi.00649-09  0.73
2007 Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies. Plos Pathogens. 3: e117. PMID 17722977 DOI: 10.1371/Journal.Ppat.0030117  0.674
2006 Meissner EG, Zhang L, Jiang S, Su L. Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus. Journal of Virology. 80: 11019-30. PMID 16956934 DOI: 10.1128/Jvi.01382-06  0.675
2005 Meissner EG, Coffield VM, Su L. Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology. 336: 184-97. PMID 15892960 DOI: 10.1016/J.Virol.2005.03.032  0.62
2004 Meissner EG, Duus KM, Gao F, Yu XF, Su L. Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology. 328: 74-88. PMID 15380360 DOI: 10.1016/J.Virol.2004.07.019  0.66
2003 Meissner EG, Duus KM, Loomis R, D'Agostin R, Su L. HIV-1 replication and pathogenesis in the human thymus. Current Hiv Research. 1: 275-85. PMID 15046252 DOI: 10.2174/1570162033485258  0.676
Show low-probability matches.